UBS raises Ryan Specialty price target to $52

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

UBS analyst Brian Meredith maintains a Buy rating on Ryan Specialty Holdings, raising the price target to $52 from $51, reflecting a positive outlook on the company's stock performance.

powered bylight_fuzz_icon
42566640

*this image is generated using AI for illustrative purposes only.

UBS analyst Brian Meredith has maintained a Buy rating on Ryan Specialty Holdings and raised the price target to $52 from $51. The revised target indicates confidence in the company's future growth prospects.

Rating and Target Details

The decision to upgrade the price target comes after a review of the company's financial health and market position. Ryan Specialty Holdings continues to show strong potential in its sector.

Metric Value
Rating Buy
Previous Price Target $51
New Price Target $52

The adjustment underscores the analyst's belief in the stock's ability to deliver value to shareholders. Investors are advised to consider the revised target in their investment decisions.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific growth drivers are expected to support the revised price target?

How might Ryan Specialty Holdings' market position evolve in the coming year?

What are the potential risks that could impact the company's ability to meet the new target?

like17
dislike

Goldman Sachs downgrades Ryan Specialty Holdings to Neutral

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Goldman Sachs analyst Robert Cox downgraded Ryan Specialty Holdings from Buy to Neutral and reduced the price target to $35 from $42.

powered bylight_fuzz_icon
42490549

*this image is generated using AI for illustrative purposes only.

Goldman Sachs analyst Robert Cox has downgraded Ryan Specialty Holdings from Buy to Neutral and lowered the price target to $35 from $42. The adjustment reflects a revised outlook on the stock's performance potential.

Rating and Price Target Changes

The downgrade moves the stock out of the Buy category, signaling a shift in the firm's expectation for future returns. The new price target of $35 represents a decrease from the prior target of $42.

Metric Previous Value New Value
Rating Buy Neutral
Price Target $42 $35
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors led Goldman Sachs to revise Ryan Specialty Holdings' performance potential?

How might this downgrade influence other analysts' ratings on Ryan Specialty Holdings in the near term?

What impact could this rating change have on Ryan Specialty Holdings' stock price in the next quarter?

like15
dislike